enGenes Biotech – Showing end-to-end bioprocessing at BIO-Europe 2025

Vienna, Austria: – enGenes Biotech GmbH (enGenes) will show its highly advanced bioprocessing solutions in protein expression and vaccine development at Europe’s flagship life sciences partnering conference, BIO-Europe 2025, this year in Vienna.

The enGenes team will join other hi-tech biotech companies as part of a combined national presence at the Austrian Pavilion operated by LISAvienna, located at C32 GL in Hall C of the Messe Wien expo center.

Enhanced yield expression

The enGenes stand displays will showcase its unique proprietary high-yield expression and purification platforms, its end-to-end bioprocessing services and innovative products, including endonuclease and affinity ligands for faster vaccine development.

Business Development Manager Dr. Ophelia Gevaert will lead the enGenes presence on stand and at BIO-Europe’s many online and face-to-face networking opportunities.

High performance bioprocessing

“We are delighted that Bio-Europe with its excellent opportunities to strengthen ties with existing partners and explore new collaboration opportunities is this year being held in our home city of Vienna and that we will be able to join in representing the vibrant Austrian biotech community,” said Ophelia Gevaert.

To read more, follow: https://www.pharmaceutical-networking.com/engenes-biotech-showing-end-to-end-bioprocessing-at-bio-europe-2025/